Several provinces reported a large number of Chinese Herbal Pieces unqualified
December 4 the grass-roots medical institutions, especially clinics and village clinics, which manage Chinese herbal pieces, should pay attention to these Chinese herbal pieces should not be used. Recently, the drug administration of Shandong Province, Fujian Province and Sichuan Province issued the list of hundreds of batches of unqualified Chinese herbal pieces, most of which are Chinese herbal pieces. On November 28, Shandong Provincial Food and Drug Administration issued the notice of drug quality sampling (issue 6, 2019). According to the notice, 40 varieties and 98 batches of drugs of 62 production enterprises (preparation units) failed to meet the requirements of the standard through sampling inspection. As required, the relevant municipal market supervision and Administration Bureau shall strengthen the supervision of the non-conforming products and the corresponding production and operation enterprises and units, supervise and urge them to find out the causes of the problems, formulate and implement the rectification measures, and effectively eliminate the potential risks. On November 28, Fujian Provincial Drug Administration issued the drug quality announcement (No. 3 in 2019, No. 77 in total). In order to strengthen the drug quality supervision and ensure the public drug safety, according to the drug sampling work plan of Fujian Province, the provincial and municipal drug regulatory departments and drug inspection institutions supervised the drug quality of drug production, trading enterprises and users in Fujian Province. In accordance with the provisions of the drug administration law of the people's Republic of China and the regulations for the implementation of the drug administration law of the people's Republic of China, 49 batches of drugs found in the drug sampling inspection that do not meet the standards are announced. Recently, according to the requirements of the drug sampling plan in 2019, the drug supervision and administration departments of all cities (prefectures) announced the list of 12 batches of unqualified drugs in Sichuan Province The drug production, marketing and use units conducted spot check.
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
Evonik Expands Slovakian Fermas Site with €80 Million Investment to Boost Pharmaceutical CDMO Capacity
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
CPHI Korea 2022
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
Industrialization Progress of genetically modified pharmaceutical products
-
2022 Top 50 Global Pharmaceutical Companies Released! Pfizer Returns to NO.1, Kexing Counterattack First on the List
Recommend Reading
-
EU Clears a New Gut Health Ingredient
-
Strait of Hormuz Reopens, Oil Prices Plunge: Is the Chemical Price Rally Over?
-
Nestlé Drops Artificial Colors Worldwide
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
A Faster Route to Diabetes Drug Chemistry
-
Business Society’s Trend Analysis for Hydrofluoric Acid on September 15, 2026: Weak Fluctuations with a Bearish Bias
-
Business Society’s DOP Market Outlook on August 24, 2026: Short-Term Correction
-
U.S. Announces Preliminary Dumping Margins of Up to 70.21% on Chinese Xanthan Gum
-
Business Society’s DOP Trend Analysis for September 16, 2026: Volatile with a Slight Bullish Bias
-
Business Society’s Market Outlook for Formic Acid on August 24, 2026: Volatile